The Detail
A1C results become more comparable when measurement systems are anchored to a common reference. NGSP maintains a network of reference laboratories and a certification process tied to the assay used in the Diabetes Control and Complications Trial, often shortened to DCCT. Secondary reference laboratories work with manufacturers and laboratories to compare results and document traceability.
The current NGSP criteria summary describes manufacturer method certification and two levels of laboratory certification. The process uses a comparison of 40 patient samples and evaluates how closely results agree with a Secondary Reference Laboratory. Successful participants receive a certificate of traceability. The criteria page, not a remembered number from an old article, should be checked when a current decision depends on the details.
Certification is bounded. NGSP states that a certificate is effective for one year and is specific to the reagents and instrumentation used during certification. Its published method list identifies configurations and certification dates. A brand may sell multiple systems, so a company name alone is not enough to establish that the particular method on a report appears on the current list.
Traceability in Plain Language
Traceability describes a documented measurement relationship. In this setting, it means results from a defined method have been compared through the NGSP network to the DCCT reference system. It helps laboratories and clinicians interpret A1C on a harmonized scale instead of treating every instrument as an isolated ruler.
Think of two rulers made to reproduce the same reference length. Passing a comparison gives evidence that one ruler agreed within the stated criteria under the evaluated conditions. It does not prove the ruler can never be damaged, misread, or used on the wrong object. In the same way, method certification supports standardization but does not erase specimen problems, operator errors, biological limitations, calibration drift, or a substance that affects a particular assay principle.
Match More Than the Manufacturer Name
A careful reader looks for the method or instrument named on the report and compares it with the current NGSP list. The match may require the manufacturer, analyzer, assay name, and sometimes configuration details. The certification date matters because certificates expire. If the report does not identify the method, the performing laboratory may be able to provide that information.
The distinction between a certified manufacturer method and a certified laboratory also matters. A method certificate concerns a specified measurement configuration. A laboratory certificate concerns the participating laboratory under its certification category. Neither phrase should be silently expanded into a claim that every test sold by a manufacturer or every procedure performed by a laboratory has NGSP certification.
- Exact assay and analyzer name, not merely the corporate brand
- Certification type and the entity named on the certificate
- Effective period or date shown in the current NGSP records
- Reagent, calibrator, software, or configuration details when they define the listed method
- Whether the specimen and use follow the method's own validated instructions
A Worked Example
Illustrative data, not patient results.Imagine a report that names only Meridian A1C Platform. A search result shows several similarly named entries. The table demonstrates a document-checking process, not a judgment about a real manufacturer. The correct conclusion at each stage is limited to the evidence actually found.
Even after an exact, current match, the reader can say that the listed configuration held NGSP certification for the relevant period. The reader cannot add FDA approved, free from interference, or correct for this specimen unless separate evidence supports those statements. Careful language preserves the real value of the certification instead of turning it into an all-purpose seal.
| Evidence found | Supported statement | Statement not yet supported |
|---|---|---|
| Manufacturer name only | A possible list match exists | This exact method is certified |
| Exact analyzer and assay match | The listed configuration can be evaluated | The certificate covered the test date |
| Current certificate period also matches | The configuration was certified for that period | The result had no interference |
| Separate interference information reviewed | Named limitations can be described | Every individual result is accurate |
Certification and Interference Answer Different Questions
NGSP publishes a separate interference table because standardization and interference are not the same property. Hemoglobin C, S, E, and D traits, elevated fetal hemoglobin, and chemically modified hemoglobin can affect methods differently. The table is method-specific and based on available published information and product labeling. A yes for one method cannot be transferred to another, and a no is limited to the factor and conditions studied.
There is also a biological issue that no assay redesign can fully remove: a condition that changes the average age or survival of red blood cells can change how A1C relates to glucose exposure. NGSP notes that shortened red cell survival can lower A1C regardless of assay method. This is why a technically standardized measurement may still require contextual interpretation by a qualified professional.
What It Does Not Tell You
NGSP certification is not FDA approval, clearance, authorization, or endorsement. FDA review and NGSP certification are separate processes with different questions. Certification also does not establish a product's intended use. Monitoring, screening, diagnosis, prescription status, over-the-counter status, and eligible populations must be read from the product-specific labeling and regulatory record.
Certification does not guarantee that every laboratory result is error-free. It does not certify every reagent lot individually, replace a laboratory's quality system, establish correct sample identity, or prove that transport and collection requirements were met. It does not show that a result is appropriate for a personal decision, and it cannot resolve a discrepancy between A1C and other records without additional information.
A More Accurate Way to Describe the Evidence
Good wording names the object and the boundary: This assay and analyzer configuration appeared on the NGSP certified-method list for the relevant certificate period. If the evidence comes from a laboratory certificate, name the laboratory and certification category instead. Add the date checked because lists and certificates change.
If a report is unclear, ask the performing laboratory for the method name and any applicable result notes. Questions about a personal result belong with a qualified healthcare professional who can consider the clinical context. For general reading, keep three columns separate: traceability evidence, regulatory intended use, and known limitations. That separation prevents a precise technical credential from being stretched into a medical promise it was never designed to make.